Welcome!

News Feed Item

PPD Beach2Battleship Heroes Promote Participation in Clinical Trials

Pharmaceutical Product Development, LLC (PPD) today announced the 2014 PPD Heroes team of athletes competing in the Oct. 25 PPD Beach2Battleship Triathlon, one of the top-rated iron distance events in the world.

PPD Heroes, everyday people who overcame illness with medical treatments developed through clinical research, raise awareness about the importance of increasing participation in clinical trials, which are integral to developing next-generation medicines. PPD Heroes will share their inspirational stories at the PPD Hero Awards, an invitation-only celebration at the company’s world headquarters in Wilmington on Oct. 24, a day before competing in the triathlon.

“PPD Heroes’ remarkable journeys from illness to wellness inspire researchers working tirelessly to develop new medical treatments,” said David Simmons, chairman and CEO of PPD. “Their advocacy to increase understanding about clinical trials is important in helping patients and physicians become aware of innovative treatment options. Increasing participation in clinical trials also helps researchers advance the pace of medical breakthroughs that can improve health and save lives.”

The 2014 team of PPD Heroes features:

  • Wendy Chioji, who was diagnosed with stage 2 breast cancer in 2001. She enrolled in a clinical trial at the urging of her oncologist, who was also her marathon training partner, to potentially help herself while advancing research for others. The resulting chemotherapy successfully treated Wendy’s breast cancer.
  • Tim Fortuna, an emergency room physician and triathlete, felt pain and discomfort in his chest following a long day of training five days after turning 37. Tests revealed a 70 percent blockage of a coronary artery. Cardiologists implanted a drug-eluting stent, which allowed the father of two to return to daily activities and again compete in triathlons.
  • Laura Hull was diagnosed with ulcerative colitis at age 24 and spent 15 years battling the disease and accompanying symptoms. Before a surgical procedure provided relief, she participated in a clinical trial testing new medication to help further the advancement of effective treatments for ulcerative colitis.
  • Mary Kreis, at 23 weeks pregnant, needed surgery to remove a cancerous mole and a sentinel lymph node. Surgeons discovered the cancer had spread, and a second operation removed additional lymph nodes. Thanks to results from previous clinical trials, Mary’s oncologist was confident the procedure was safe for a pregnant patient. Weeks later, Mary gave birth to a healthy baby girl.
  • Meg Roberts, diagnosed with type 1 diabetes at age 10, credits clinical researchers for developing therapies that help her manage the condition. As there is no cure for diabetes, to stay healthy she must inject insulin several times a day. Over the years, clinical research aided the development of insulin and enhanced blood glucose monitoring methods.
  • Chris Samia was diagnosed with psoriasis in the seventh grade. He underwent various types of treatments for the next 15 years and was unable to be physically active because of the painful condition affecting nearly all the skin on his body. At 27 and obese, Chris participated in a clinical trial for a medication that relieved his symptoms and transformed his life, allowing him to lose more than 100 pounds and compete as a triathlete.
  • Emily Schaller, a cystic fibrosis (CF) patient and founder of the Rock CF Foundation, has participated in multiple clinical trials. In 1983, at 18 months old, she was diagnosed with CF at a time when the median age of survival was in the late teens. She began participating in clinical trials in her early teens and has volunteered for trials of breakthrough CF therapies.

PPD is celebrating its fifth year as title sponsor of the PPD Beach2Battleship Triathlon, which has been ranked among the top five triathlons in the world by readers of Triathlete magazine. The race starts in Wrightsville Beach, winds through New Hanover, Pender, Sampson and Bladen counties and ends in downtown Wilmington. The full iron distance triathlon includes a 2.4-mile swim, a 112-mile bike ride and a 26.2-mile run. The event also offers a half iron distance triathlon course.

The PPD Beach2Battleship Triathlon last month announced the addition of the New Hanover Regional Medical Center (NHRMC) 5K to the lineup of race weekend events, providing an expanded opportunity for participation. The NHRMC 5K will be held the morning of the triathlon, starting at 9 a.m. at Legion Stadium, running along the streets of Greenfield Lake and downtown Wilmington, and ending at the PPD Beach2Battleship Triathlon finish line on Water Street.

More than 2,000 athletes participate in the PPD Beach2Battleship Triathlon, helping generate approximately $4 million in local economic impact. Funds raised benefit the Wilmington Family YMCA. PPD Beach2Battleship is produced by Set Up Events, one of the largest triathlon production companies in the United States, producing more than 150 events annually in eight states.

About PPD

PPD is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 13,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.

Except for historical information, all of the statements, expectations and assumptions, including statements, expectations and assumptions about the PPD Beach2Battleship Triathlon, contained in this news release are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based and could cause actual results to differ materially from the forward-looking statements. Other important factors that could cause future results to differ materially include the following: the ability to attract, integrate, retain and train key personnel; competition in the outsourcing industry; PPD’s ability to win new business; the ability to control SG&A spending; overall global economic conditions; economic conditions, research and development spending, and outsourcing trends in the pharmaceutical, biotechnology and government-sponsored research sectors; loss, delay or modification of large contracts; higher-than-expected cancellation rates; the rate of conversion of backlog into revenue; risks associated with acquisitions and investments; rapid technological advances that make our services or capabilities less competitive; compliance with drug development regulations; changes in the regulation of the drug development process; consolidation in the pharmaceutical and biotechnology industries; risks associated with and dependence on strategic relationships; and actual operating performance. PPD assumes no obligation and expressly disclaims any duty to update these forward-looking statements in the future, except as required by applicable law. These forward-looking statements should not be relied upon as representing PPD’s estimates or views as of any date subsequent to the date hereof.

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions need to be truly scalable. Far from it. There are at least six major pain points that companies experience when they try to deploy and run Kubernetes in their complex environments. In this presentation, the speaker will d...
While DevOps most critically and famously fosters collaboration, communication, and integration through cultural change, culture is more of an output than an input. In order to actively drive cultural evolution, organizations must make substantial organizational and process changes, and adopt new technologies, to encourage a DevOps culture. Moderated by Andi Mann, panelists discussed how to balance these three pillars of DevOps, where to focus attention (and resources), where organizations might...
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...
When building large, cloud-based applications that operate at a high scale, it's important to maintain a high availability and resilience to failures. In order to do that, you must be tolerant of failures, even in light of failures in other areas of your application. "Fly two mistakes high" is an old adage in the radio control airplane hobby. It means, fly high enough so that if you make a mistake, you can continue flying with room to still make mistakes. In his session at 18th Cloud Expo, Le...
Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performance data from large automated systems such as heating and cooling to the people that live and work within them. Through machine learning, buildings can optimize performance, reduce costs, and improve occupant comfort by ...
As Cybric's Chief Technology Officer, Mike D. Kail is responsible for the strategic vision and technical direction of the platform. Prior to founding Cybric, Mike was Yahoo's CIO and SVP of Infrastructure, where he led the IT and Data Center functions for the company. He has more than 24 years of IT Operations experience with a focus on highly-scalable architectures.
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
CI/CD is conceptually straightforward, yet often technically intricate to implement since it requires time and opportunities to develop intimate understanding on not only DevOps processes and operations, but likely product integrations with multiple platforms. This session intends to bridge the gap by offering an intense learning experience while witnessing the processes and operations to build from zero to a simple, yet functional CI/CD pipeline integrated with Jenkins, Github, Docker and Azure...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Dhiraj Sehgal works in Delphix's product and solution organization. His focus has been DevOps, DataOps, private cloud and datacenters customers, technologies and products. He has wealth of experience in cloud focused and virtualized technologies ranging from compute, networking to storage. He has spoken at Cloud Expo for last 3 years now in New York and Santa Clara.
Enterprises are striving to become digital businesses for differentiated innovation and customer-centricity. Traditionally, they focused on digitizing processes and paper workflow. To be a disruptor and compete against new players, they need to gain insight into business data and innovate at scale. Cloud and cognitive technologies can help them leverage hidden data in SAP/ERP systems to fuel their businesses to accelerate digital transformation success.
Containers and Kubernetes allow for code portability across on-premise VMs, bare metal, or multiple cloud provider environments. Yet, despite this portability promise, developers may include configuration and application definitions that constrain or even eliminate application portability. In this session we'll describe best practices for "configuration as code" in a Kubernetes environment. We will demonstrate how a properly constructed containerized app can be deployed to both Amazon and Azure ...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.